- call +1-201-465-4211
- email sales@mrinsights.biz
Peptide glycosylation is a covalent modification that can potentially improve the physicochemical properties of peptides.
Scope of the Report:
Some advantages of glycosylated peptides include: (1) increased bioavailability, (2) increased metabolic stability, (2) targeting specific tissues and organs, (3) reduction in clearance rates, (4) enhanced receptor binding, (5) facilitation of active transport across cell membranes (glucose transporters), and (6) maintaining the overall physical properties of peptides (precipitation, aggregation, thermal and kinetic denaturation).
Glycopeptides are recognized as peptides that contain glycans (carbohydrate molecules) and can be generalized classified into three types based on the linkage or bond type between the amino acid and the glycan: (1) C-linked, (2) O-linked, and (3) N-linked.
The most common type in eukaryotic cells is N-linked glycopeptides, noted by the C-N bond from the side chain of asparagine (Asn/N) amino acid. O-Type glycopeptides are named after the C-O bond from the side chains of serine (Ser) and threonine (Thr) amino acids. The least common C-linked types are recognized as the bond between a tryptophan residue and the sugar mannose.
The worldwide market for Glycosylated Peptide is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
This report focuses on the Glycosylated Peptide in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Sandoz International
Pfizer
Roche
Teva Pharmaceuticals Industries
Celltrion
Biocon
Dr.Reddys Laboratories
Medtronic
Cipla
Bachem Americas
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Monoclonal Antibodies (MABs)
Erythropoietin (EPO)
Others
Market Segment by Applications, can be divided into
Oncology
Blood Disorder
Others
There are 15 Chapters to deeply display the global Glycosylated Peptide market.
Chapter 1, to describe Glycosylated Peptide Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Glycosylated Peptide, with sales, revenue, and price of Glycosylated Peptide, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Glycosylated Peptide, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Glycosylated Peptide market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Glycosylated Peptide sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Glycosylated Peptide Introduction
1.2 Market Analysis by Type
1.2.1 Monoclonal Antibodies (MABs)
1.2.2 Erythropoietin (EPO)
1.2.3 Others
1.3 Market Analysis by Applications
1.3.1 Oncology
1.3.2 Blood Disorder
1.3.3 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Sandoz International
2.1.1 Business Overview
2.1.2 Glycosylated Peptide Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Sandoz International Glycosylated Peptide Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Pfizer
2.2.1 Business Overview
2.2.2 Glycosylated Peptide Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Pfizer Glycosylated Peptide Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Roche
2.3.1 Business Overview
2.3.2 Glycosylated Peptide Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Roche Glycosylated Peptide Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Teva Pharmaceuticals Industries
2.4.1 Business Overview
2.4.2 Glycosylated Peptide Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Teva Pharmaceuticals Industries Glycosylated Peptide Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Celltrion
2.5.1 Business Overview
2.5.2 Glycosylated Peptide Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Celltrion Glycosylated Peptide Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Biocon
2.6.1 Business Overview
2.6.2 Glycosylated Peptide Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Biocon Glycosylated Peptide Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Dr.Reddys Laboratories
2.7.1 Business Overview
2.7.2 Glycosylated Peptide Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Dr.Reddys Laboratories Glycosylated Peptide Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Medtronic
2.8.1 Business Overview
2.8.2 Glycosylated Peptide Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Medtronic Glycosylated Peptide Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Cipla
2.9.1 Business Overview
2.9.2 Glycosylated Peptide Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Cipla Glycosylated Peptide Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Bachem Americas
2.10.1 Business Overview
2.10.2 Glycosylated Peptide Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Bachem Americas Glycosylated Peptide Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Glycosylated Peptide Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Glycosylated Peptide Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Glycosylated Peptide Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Glycosylated Peptide Manufacturer Market Share in 2017
3.3.2 Top 6 Glycosylated Peptide Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Glycosylated Peptide Market Analysis by Regions
4.1 Global Glycosylated Peptide Sales, Revenue and Market Share by Regions
4.1.1 Global Glycosylated Peptide Sales and Market Share by Regions (2013-2018)
4.1.2 Global Glycosylated Peptide Revenue and Market Share by Regions (2013-2018)
4.2 North America Glycosylated Peptide Sales and Growth Rate (2013-2018)
4.3 Europe Glycosylated Peptide Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Glycosylated Peptide Sales and Growth Rate (2013-2018)
4.5 South America Glycosylated Peptide Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Glycosylated Peptide Sales and Growth Rate (2013-2018)
5 North America Glycosylated Peptide by Countries
5.1 North America Glycosylated Peptide Sales, Revenue and Market Share by Countries
5.1.1 North America Glycosylated Peptide Sales and Market Share by Countries (2013-2018)
5.1.2 North America Glycosylated Peptide Revenue and Market Share by Countries (2013-2018)
5.2 United States Glycosylated Peptide Sales and Growth Rate (2013-2018)
5.3 Canada Glycosylated Peptide Sales and Growth Rate (2013-2018)
5.4 Mexico Glycosylated Peptide Sales and Growth Rate (2013-2018)
6 Europe Glycosylated Peptide by Countries
6.1 Europe Glycosylated Peptide Sales, Revenue and Market Share by Countries
6.1.1 Europe Glycosylated Peptide Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Glycosylated Peptide Revenue and Market Share by Countries (2013-2018)
6.2 Germany Glycosylated Peptide Sales and Growth Rate (2013-2018)
6.3 UK Glycosylated Peptide Sales and Growth Rate (2013-2018)
6.4 France Glycosylated Peptide Sales and Growth Rate (2013-2018)
6.5 Russia Glycosylated Peptide Sales and Growth Rate (2013-2018)
6.6 Italy Glycosylated Peptide Sales and Growth Rate (2013-2018)
7 Asia-Pacific Glycosylated Peptide by Countries
7.1 Asia-Pacific Glycosylated Peptide Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Glycosylated Peptide Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Glycosylated Peptide Revenue and Market Share by Countries (2013-2018)
7.2 China Glycosylated Peptide Sales and Growth Rate (2013-2018)
7.3 Japan Glycosylated Peptide Sales and Growth Rate (2013-2018)
7.4 Korea Glycosylated Peptide Sales and Growth Rate (2013-2018)
7.5 India Glycosylated Peptide Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Glycosylated Peptide Sales and Growth Rate (2013-2018)
8 South America Glycosylated Peptide by Countries
8.1 South America Glycosylated Peptide Sales, Revenue and Market Share by Countries
8.1.1 South America Glycosylated Peptide Sales and Market Share by Countries (2013-2018)
8.1.2 South America Glycosylated Peptide Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Glycosylated Peptide Sales and Growth Rate (2013-2018)
8.3 Argentina Glycosylated Peptide Sales and Growth Rate (2013-2018)
8.4 Colombia Glycosylated Peptide Sales and Growth Rate (2013-2018)
9 Middle East and Africa Glycosylated Peptide by Countries
9.1 Middle East and Africa Glycosylated Peptide Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Glycosylated Peptide Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Glycosylated Peptide Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Glycosylated Peptide Sales and Growth Rate (2013-2018)
9.3 UAE Glycosylated Peptide Sales and Growth Rate (2013-2018)
9.4 Egypt Glycosylated Peptide Sales and Growth Rate (2013-2018)
9.5 Nigeria Glycosylated Peptide Sales and Growth Rate (2013-2018)
9.6 South Africa Glycosylated Peptide Sales and Growth Rate (2013-2018)
10 Global Glycosylated Peptide Market Segment by Type
10.1 Global Glycosylated Peptide Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Glycosylated Peptide Sales and Market Share by Type (2013-2018)
10.1.2 Global Glycosylated Peptide Revenue and Market Share by Type (2013-2018)
10.2 Monoclonal Antibodies (MABs) Sales Growth and Price
10.2.1 Global Monoclonal Antibodies (MABs) Sales Growth (2013-2018)
10.2.2 Global Monoclonal Antibodies (MABs) Price (2013-2018)
10.3 Erythropoietin (EPO) Sales Growth and Price
10.3.1 Global Erythropoietin (EPO) Sales Growth (2013-2018)
10.3.2 Global Erythropoietin (EPO) Price (2013-2018)
10.4 Others Sales Growth and Price
10.4.1 Global Others Sales Growth (2013-2018)
10.4.2 Global Others Price (2013-2018)
11 Global Glycosylated Peptide Market Segment by Application
11.1 Global Glycosylated Peptide Sales Market Share by Application (2013-2018)
11.2 Oncology Sales Growth (2013-2018)
11.3 Blood Disorder Sales Growth (2013-2018)
11.4 Others Sales Growth (2013-2018)
12 Glycosylated Peptide Market Forecast (2018-2023)
12.1 Global Glycosylated Peptide Sales, Revenue and Growth Rate (2018-2023)
12.2 Glycosylated Peptide Market Forecast by Regions (2018-2023)
12.2.1 North America Glycosylated Peptide Market Forecast (2018-2023)
12.2.2 Europe Glycosylated Peptide Market Forecast (2018-2023)
12.2.3 Asia-Pacific Glycosylated Peptide Market Forecast (2018-2023)
12.2.4 South America Glycosylated Peptide Market Forecast (2018-2023)
12.2.5 Middle East and Africa Glycosylated Peptide Market Forecast (2018-2023)
12.3 Glycosylated Peptide Market Forecast by Type (2018-2023)
12.3.1 Global Glycosylated Peptide Sales Forecast by Type (2018-2023)
12.3.2 Global Glycosylated Peptide Market Share Forecast by Type (2018-2023)
12.4 Glycosylated Peptide Market Forecast by Application (2018-2023)
12.4.1 Global Glycosylated Peptide Sales Forecast by Application (2018-2023)
12.4.2 Global Glycosylated Peptide Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Glycosylated Peptide Picture
Table Product Specifications of Glycosylated Peptide
Figure Global Sales Market Share of Glycosylated Peptide by Types in 2017
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
